Mar Masiá

Has grant

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Factores inmunológicos, bacteriológicos y virológicos potencialmente implicados en la recurrencia de displasia anal de alto grado en personas con VIH

Open Date: 2023-01-01

Close Date: 2025-12-01

Grant: Close

Estudio piloto para evaluar la eficacia y seguridad de la mefloquina como profilaxis en personas expuestas a la enfermedad producida por coronavirus SARS-CoV-2 (COVID-19)

Open Date: 2020-04-01

Close Date: 2021-04-01

Grant: Close

IMpacto de un Programa Ampliado de Cribado en la detección de NEOplasiasmalignas no-sida en pacientes con infección por el VIH (IMPAC-NEO)

Open Date: 2019-01-01

Close Date: 2023-06-01

Grant: Close

Influencia de la composición del microbioma intestinal en la progresión de la arteriosclerosis en pacientes con infección por el VIH en tratamiento antirretroviral eficaz

Open Date: 2017-01-01

Close Date: 2021-06-01

Grant: Close

Redes Temáticas de Investigación Cooperativa en Salud-Red de Investigación en Sida Instituto de Salud Carlos III

Open Date: 2017-01-01

Close Date: 2021-12-01

Articles (13)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

SPAIN

View details

JOSE ALBERTO GARCIA GOMEZ

Universidad Miguel Hernández de Elche

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mar Masiá

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (13)

Distinct Gut Microbiota Signatures Associated With Progression of Atherosclerosis in People Living With Human Immunodeficiency Virus

T-Cell Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Measured by an Interferon-γ Release Assay Is Strongly Associated With Patient Outcomes in Vaccinated Persons Hospitalized With Delta or Omicron Variants

Systematic screening of gender violence and domestic violence among HIV-positive patients: the VIHOLETA study

Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens

Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir

Integrating SARS-CoV-2-specific interferon-γ release assay testing in the evaluation of patients hospitalized with COVID-19

Cancer screening in people living with HIV

Robust long-term immunity to SARS-CoV-2 in patients recovered from severe COVID-19 after interleukin-6 blockade

Pericarditis caused by Mycobacterium africanum: case report

Immunologic phenotype of patients with long-COVID syndrome of 1-year duration

Human Immunodeficiency Virus Type 1 RNA Levels in Rectal and Seminal Compartments After Switching to Long-Acting Cabotegravir Plus Rilpivirine: A Longitudinal Study

Survival benefit of remdesivir in hospitalized COVID-19 patients with high SARS-CoV-2 viral loads and low-grade systemic inflammation

Clinical performance of a standardized SARS-CoV-2 interferon-γ release assay for simple detection of T-cell responses after infection or vaccination

Collaborators (6)

Félix Gutiérrez

Kristina Polotskaya

Jara Llenas-García

Luis Enrique Morano Amado

ESTEBAN MARTINEZ

JOSE ALBERTO GARCIA GOMEZ

Make your next move.